SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-008455
Filing Date
2020-05-27
Accepted
2020-05-27 11:07:54
Documents
6
Period of Report
2020-05-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf8-k052720.htm 8-K 45794
2 EX-4.1 a41crdf052720.htm EX-4.1 226669
3 EX-10.1 a101crdf052720.htm EX-10.1 380067
4 EX-99.1 a991crdf052720.htm EX-99.1 18919
5 cardifflogorgbtm1.jpg GRAPHIC 176318
6 image01.jpg GRAPHIC 50931
  Complete submission text file 0001628280-20-008455.txt   971240
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 20913756
SIC: 2836 Biological Products, (No Diagnostic Substances)